Counterpoint: Both immunohistochemistry and fluorescence in situ hybridization play important roles for HER2 evaluation

Clin Chem. 2011 Jul;57(7):983-5. doi: 10.1373/clinchem.2010.160853. Epub 2011 May 10.
No abstract available

Publication types

  • Comment
  • Comparative Study

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / therapeutic use
  • Breast Neoplasms / diagnosis
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / pathology
  • Female
  • Gene Amplification
  • Humans
  • Immunohistochemistry*
  • In Situ Hybridization, Fluorescence*
  • Molecular Targeted Therapy
  • Receptor, ErbB-2 / genetics
  • Receptor, ErbB-2 / metabolism*
  • Stomach Neoplasms / diagnosis
  • Stomach Neoplasms / drug therapy
  • Stomach Neoplasms / metabolism
  • Trastuzumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • ERBB2 protein, human
  • Receptor, ErbB-2
  • Trastuzumab